Health Condition 1: K319- Disease of stomach and duodenum, unspecified
Conditions
Interventions
Intervention1: Eligible participants will be randomly assigned in a 1 1 1 1 ratio to one of the four treatment arms using a computer generated randomisation sequence prepared by an independent statist
Sponsors
Dr Naresh Agrawal
Eligibility
Inclusion criteria
Inclusion criteria: Age 18 65 years Confirmed H pylori infection by endoscopy rapid urease test (RUT) Urea breath test
Exclusion criteria
Exclusion criteria: Prior H pylori eradication therapy within 6 months Allergy or intolerance to any study drugs Antibiotic or PPI use within 4 weeks prior to enrolment Pregnancy or lactation Severe liver kidney or cardiovascular disease neurological or oncological disease History of gastric surgery or malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| H Pylori eradication Rate ( UBT confirmed)Timepoint: After completion of the drug administration phase weekly telephonic follow ups will be conducted for three consecutive weeks followed by an in person follow up visit at week four After therapy At Baseline At week 1st telephonic At week 2nd telephonic At week 3rd telephonic At week 4th In Person | — |
Secondary
| Measure | Time frame |
|---|---|
| Major And Minor Adverse Events Compliance And discontinuation rateTimepoint: After completion of the drug administration phase weekly telephonic follow ups will be conducted for three consecutive weeks followed by an in person follow up visit at week four | — |
Countries
India
Contacts
Public ContactDr Naresh Agarwal
Max Super Speciality Hospital Patparganj (A Unit of Balaji Medical and Diagnostic Research Centre)
Outcome results
None listed